Tyme Technologies Inc Stock News

Tyme Technologies, Inc. (TYME) with the stream of -5.82% also noticed, India Ault Global Holdings, Inc. (DPW) encountered a rapid change of 0.00% in the last hour of Mondays trading The post Latest Tally Of Analyst Opinions: Tyme Technologies, Inc. (NASDAQ:TYME), Ault Global Holdings, Inc. (AMEX:DPW) appeared first on Stocks Equity .

Cocrystal Pharma, Inc. (COCP) with the stream of 18.57% also noticed, India Tyme Technologies, Inc. (TYME) encountered a rapid change of -2.32% in the last hour of trading session. Cocrystal The post Volume Buzz: Cocrystal Pharma, Inc. (NASDAQ:COCP), Tyme Technologies, Inc. (NASDAQ:TYME) appeared first on Stocks Equity .

Tyme Technologies, Inc. (TYME) with the stream of -2.32% also noticed, India PEDEVCO Corp. (PED) encountered a rapid change of -0.87% in the last hour of Fridays trading session. Tyme The post Bright Trending Stock: Tyme Technologies, Inc. (NASDAQ:TYME), PEDEVCO Corp. (AMEX:PED) appeared first on Stocks Equity .

Tyme Technologies Inc. (NASDAQ:TYME) shares, rose in value on Wednesday, 11/24/21, with the stock price up by 6.64% to the previous days close as strong demand from buyers drove the stock to $0.80. Actively observing the price movement in the last trading, the stock closed the session at $0.75, falling within a range of $0.73 Thinking Of Buying Tyme Technologies Inc. (NASDAQ: TYME) Stock? Here Is What You Should Know Read More »

Geode Capital Management LLC lessened its position in shares of Tyme Technologies, Inc. (NASDAQ:TYME) by 35.5% during the second quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 828,948 shares of the companys stock after selling 455,682 shares during the quarter. Geode Capital Management LLC owned about 0.48% []

Tyme Technologies, Inc. (TYME) CEO Richie Cunningham on Q2 2021 Results - Earnings Call Transcript

BEDMINSTER, N.J.--(BUSINESS WIRE)--TYME Technologies, Inc. (Nasdaq: TYME) (the Company or TYME), an emerging biotechnology company developing cancer metabolism-based therapies (CMBTs™), today announ

BEDMINSTER, N.J.--(BUSINESS WIRE)--TYME Technologies, Inc. (“TYME” or the “Company”) (NASDAQ: TYME), an emerging biotechnology company developing cancer metabolism-based therapies (CMBTs™),

BEDMINSTER, N.J.--(BUSINESS WIRE)--TYME Technologies, Inc. (Nasdaq: TYME) (the “Company” or “TYME”), an emerging biotechnology company developing cancer metabolism-based therapies (CMBTs™),

Tyme Technologies recently made some big moves following a strategic review. I believe the market has missed the bullish memo about these changes. I review some of these significant changes and provid

Tyme Technologies, Inc. (TYME) CEO Richie Cunningham on Q1 Fiscal Year 2022 Results - Earnings Call Transcript

BEDMINSTER, N.J.--(BUSINESS WIRE)--TYME Technologies, Inc. (Nasdaq: TYME) (the “Company” or “TYME”), an emerging biotechnology company developing cancer metabolism-based therapies (CMBTs™),

Shares of Tyme Technologies, Inc. (NASDAQ: TYME) may have just crashed into a wall of sellers. This means the rally may be over.

TYME stock is making big moves today after it received patent approval for its cancer treatment. Now, it will move into deeper development.

BEDMINSTER, N.J.--(BUSINESS WIRE)--Tyme Technologies, Inc. (NASDAQ: TYME), an emerging biotechnology company developing cancer metabolism-based therapies (CMBTs™), announced that it has received not